Table of Contents

1 Study Coverage

• 1.1 Blood Products Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Blood Products Market Size Growth Rate by Product
  • 1.4.2 Albumin
  • 1.4.3 Immune Globulin
  • 1.4.4 Coagulation Factor
• 1.5 Market by End User
  • 1.5.1 Global Blood Products Market Size Growth Rate by End User
  • 1.5.2 Immunity
  • 1.5.3 Therapy
  • 1.5.4 Surgery
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Blood Products Market Size
  • 2.1.1 Global Blood Products Revenue 2014-2025
  • 2.1.2 Global Blood Products Sales 2014-2025
• 2.2 Blood Products Growth Rate by Regions
  • 2.2.1 Global Blood Products Sales by Regions
  • 2.2.2 Global Blood Products Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Blood Products Sales by Manufacturers
  • 3.1.1 Blood Products Sales by Manufacturers
  • 3.1.2 Blood Products Sales Market Share by Manufacturers
  • 3.1.3 Global Blood Products Market Concentration Ratio (CR5 and HHI)
• 3.2 Blood Products Revenue by Manufacturers
  • 3.2.1 Blood Products Revenue by Manufacturers (2014-2019)
  • 3.2.2 Blood Products Revenue Share by Manufacturers (2014-2019)
• 3.3 Blood Products Price by Manufacturers
• 3.4 Blood Products Manufacturing Base Distribution, Product Types
  • 3.4.1 Blood Products Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Blood Products Product Type
  • 3.4.3 Date of International Manufacturers Enter into Blood Products Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Blood Products Sales by Product
• 4.2 Global Blood Products Revenue by Product
• 4.3 Blood Products Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Blood Products Breakdown Data by End User

6 North America

• 6.1 North America Blood Products by Countries
  • 6.1.1 North America Blood Products Sales by Countries
  • 6.1.2 North America Blood Products Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Blood Products by Product
• 6.3 North America Blood Products by End User

7 Europe

• 7.1 Europe Blood Products by Countries
  • 7.1.1 Europe Blood Products Sales by Countries
  • 7.1.2 Europe Blood Products Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Blood Products by Product
• 7.3 Europe Blood Products by End User

8 Asia Pacific

• 8.1 Asia Pacific Blood Products by Countries
  • 8.1.1 Asia Pacific Blood Products Sales by Countries
  • 8.1.2 Asia Pacific Blood Products Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Blood Products by Product
• 8.3 Asia Pacific Blood Products by End User

9 Central & South America

• 9.1 Central & South America Blood Products by Countries
  • 9.1.1 Central & South America Blood Products Sales by Countries
  • 9.1.2 Central & South America Blood Products Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Blood Products by Product
• 9.3 Central & South America Blood Products by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Blood Products by Countries
  • 10.1.1 Middle East and Africa Blood Products Sales by Countries
  • 10.1.2 Middle East and Africa Blood Products Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Blood Products by Product
• 10.3 Middle East and Africa Blood Products by End User

11 Company Profiles

• 11.1 Baxter
  • 11.1.1 Baxter Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Baxter Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Baxter Blood Products Products Offered
  • 11.1.5 Baxter Recent Development
• 11.2 CSL
  • 11.2.1 CSL Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 CSL Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 CSL Blood Products Products Offered
  • 11.2.5 CSL Recent Development
• 11.3 Grifols
  • 11.3.1 Grifols Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Grifols Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Grifols Blood Products Products Offered
  • 11.3.5 Grifols Recent Development
• 11.4 Octapharma
  • 11.4.1 Octapharma Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Octapharma Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Octapharma Blood Products Products Offered
  • 11.4.5 Octapharma Recent Development
• 11.5 BPL
  • 11.5.1 BPL Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 BPL Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 BPL Blood Products Products Offered
  • 11.5.5 BPL Recent Development
• 11.6 Kedrion
  • 11.6.1 Kedrion Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Kedrion Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Kedrion Blood Products Products Offered
  • 11.6.5 Kedrion Recent Development
• 11.7 Mitsubishi Tanabe
  • 11.7.1 Mitsubishi Tanabe Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Mitsubishi Tanabe Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Mitsubishi Tanabe Blood Products Products Offered
  • 11.7.5 Mitsubishi Tanabe Recent Development
• 11.8 CBOP
  • 11.8.1 CBOP Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 CBOP Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 CBOP Blood Products Products Offered
  • 11.8.5 CBOP Recent Development
• 11.9 RAAS
  • 11.9.1 RAAS Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 RAAS Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 RAAS Blood Products Products Offered
  • 11.9.5 RAAS Recent Development
• 11.10 Hualan Bio
  • 11.10.1 Hualan Bio Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Hualan Bio Blood Products Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Hualan Bio Blood Products Products Offered
  • 11.10.5 Hualan Bio Recent Development

12 Future Forecast

• 12.1 Blood Products Market Forecast by Regions
  • 12.1.1 Global Blood Products Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Blood Products Revenue Forecast by Regions 2019-2025
• 12.2 Blood Products Market Forecast by Product
  • 12.2.1 Global Blood Products Sales Forecast by Product 2019-2025
  • 12.2.2 Global Blood Products Revenue Forecast by Product 2019-2025
• 12.3 Blood Products Market Forecast by End User
• 12.4 North America Blood Products Forecast
• 12.5 Europe Blood Products Forecast
• 12.6 Asia Pacific Blood Products Forecast
• 12.7 Central & South America Blood Products Forecast
• 12.8 Middle East and Africa Blood Products Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Blood Products Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Blood Products market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Blood Products market based on company, product type, end user and key regions.

This report studies the global market size of Blood Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood Products in these regions.
This research report categorizes the global Blood Products market by top players/brands, region, type and end user. This report also studies the global Blood Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio

Market size by Product
Albumin
Immune Globulin
Coagulation Factor
Market size by End User
Immunity
Therapy
Surgery
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Blood Products market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Blood Products market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Blood Products companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Blood Products submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Blood Products are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Blood Products market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.